Our in vitro results (Fig 1C–E; Appendix Figs S2B and S3A–D) demonstrated that the DNA damage inflicted by pyridostatin in BRCA2‐deficient cells is repaired after removal of the drug, suggesting that the toxicity of this compound is reversible and tumour growth may recover in the long term. Here, BRCA2 is linked to neoplasm.